Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis Minimal Lesion

Explore clinical trials studying Glomerulonephritis Minimal Lesion. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Glomerulonephritis Minimal Lesion trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +10 more
Locations
  • Emory Children's Center- Site Number : 8400020 Atlanta, Georgia, United States
  • Investigational Site Number : 0320001 Buenos Aires, Argentina
  • Investigational Site Number : 0320002 Córdoba, Argentina
  • Investigational Site Number : 0360003 Garran, Australian Capital Territory, Australia
View all 75 locations
View Trial Details

Related conditions